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Abstract. Tea is a highly consumed beverage with numerous health benefits, such
as antioxidant and antiviral properties. The compounds within tea that are believed to be
associated with these benefits are polyphenols. Black tea polyphenols are known as
theaflavins, and in previous studies have exhibited inhibitory effects on influenza and
human immunodeficiency virus 1. Herpes simplex virus -1 (HSV-1) is an extremely
common virus and has the ability to cause recurrent infections. A vast majority o f adults
have been exposed to the virus and could be asymptomatic. The purpose of this study was
to determine the lowest inhibitory concentration o f black tea extracts on the herpes
simplex virus -1. Utilizing plaque assays, DNA extraction, PCR, and gel electrophoresis,
it was determined that viral inhibition occurs at a concentration of O.lpg/mL BTE.
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Herpes Simplex Virus - 1
Classification. Herpes simplex virus (HSV) belongs to the Herpesviridae family,
and is a member of the Alphaherpesvirinae subfamily. There are eight human herpes
viruses, which include Herpes simplex virus 1 and 2. Biological properties such as
growth cycle, cytopathology, and location o f latent infection determine the classification
of the herpes viruses into their respective subfamilies. HSV-1 is a double-stranded DNA
virus composed of four parts: an icosahedral capsid, a core containing viral DNA, a
tegument, and an envelope accented with glycoprotein spikes. Its diameter can range
from 125nm - approximately 200nm based on whether the virion is enveloped or naked
(Brooks et al., 2010). HSV-1 contains about 150,000 base pairs, which allows it to
produce 80 gene products. The genome is separated into segments called Long or Short
as indicated by the respective lengths of each segment (Taylor et al., 2002). Each HSV
type encodes at least 70 distinctive polypeptides, of which many of their functions remain
unknown. HSV-1 exhibits a short growth cycle and establishes latent infections within
neurons (Brooks et al., 2010).

Viral Entry/Latency. HSV-1 is often transmitted via oral contact, while HSV-2
transmission occurs most often though genital contact. The transmission locations are not
exclusive to each type and may be used as a route of entry by either type o f HSV. Viruses
gain entry to host cells via different mechanisms; herpes virus type 1 exhibits multiple
entry routes. One entry mechanism is virus attachment to filopodia; filopodial bridges
were also observed between cells and assisted in the migration of extracellular HSV-1
virions from an infected to uninfected cell (Akhtar and Shukla 2009). Carfi et al (2001)
indicated that viral fusion at membranes was triggered by glycoprotein conformational
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changes. Also, the use of paired immunoglobulin-like receptor (PILR) as a co-receptor
may be utilized as a route of entry by HSV-1 (Satoh et al., 2008). HSV-1 utilizes viral
envelope proteins such as glycoprotein B, C, and D in steps to gain entry. Initially, HSV1 begins to attach to the host cell using glycoprotein C (Harold et al., 1991). Next, the
glycoprotein D and cellular receptor interaction stabilize the attachment to the host cell
(Spear et al, 2000). Subsequently, the host cellular membrane and viral envelope fuse via
an unknown mechanism (Ligas and Johnson, 1988).
Previous research indicated HSV-1 entry occurred through pH-independent viral
envelope and plasma membrane fusion (Spear, 1993). One strategy was to utilize
bioengineering to remove the recognition o f the natural receptors and replace them with a
new target receptor (Menotti et al., 2009; Zhou and Roizman, 2006). A second
mechanism was to develop an attachment bridge to transport the virus to its target.
Adaptors may function to target one specific mode of entry for HSV-1 (van Beusechem
et al., 2003; Verheije et al., 2006). O’Donnell et al (2010) stated that 3 -0 sulfated heparin
sulfate’s (3-OS HS) precursors are readily available leading to the possibility of increased
amounts of 3-OS HS. The results also suggest that HeLa, Vero, and retinal pigment
epithelia (RPE) cell lines express a unique group o f 3 -0 sulfotransferases (3-OST), which
suggests 3-OS HS may be an important receptor in HSV-1 entry. A reduction in viral
entry was observed in all cell types when either exposed to 2-OST siRNA or when cell
lines expressed decreased amounts of 3-OS HS. This further supports that 3-OS HS plays
a significant role in viral entry. 3-OS HS may be a coreceptor for nectin-1 or may have an
uninvestigated role in post-entry processes. Studies with 3-OS HS knockout mice indicate
that 3-OS HS functions in other signal pathways by the inability of the knockout mice to
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develop normally. The inhibition of 3-OS HS precursors may result in attachment,
penetration, and cell-cell fusion inhibition. Further research is required to determine why
down-regulation of 3-OS HSs precursors inhibits viral entry and cell-cell fusion as well
as the specific role of 3-OS HS in HSV-1 (O’Donnell et al., 2010). Future research
should also identify HSV protein-protein interactions during the process o f infection host
cells. Identification of the mechanisms will allow for the development o f novel anti-viral
medications and treatments (Kelly et al., 2009).
Upon entry, herpes virus establishes latent infections within humans and produces
lesions at the entry location upon reactivation. HSV incubation can last approximately 2 12 days, may excrete virus for about 7-10 days and can recur more frequently in
individuals with underlying immune deficiencies (Taylor et al., 2002; Whitley and
Roizman 2001). During latent infection, viruses are virtually undetectable in the host.
Once the virus enters the host, the infection either proceeds as lytic or latent. Latent
infections are unable to be reproduced in vitro. There are numerous regulatory
mechanisms that facilitate latency and subsequent reactivation (Bloom et al., 2010).

Replication/Assembly. The HSV-1 genome consists o f a minimum o f 79 genes,
with approximately four being diploid. Within the genome are three origins of
replication; all of which can function independently of the other origins. Viral replication
occurs within specific areas of the host cell nucleus. Most proteins utilized for replication
are virus encoded. HSV-1 exhibits highly recombinant characteristics (Bataille and
Epstein 1995). Changes within the pattern of viral gene expression results in a different
replication pattern of HSV-1, which can range from explosive replication to a complete
arrest. With increased early gene activity comes faster replication speed. Mutations in the
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promoter have the ability to increase or decrease binding affinity. The replication speed
of a virus is more important than replication efficiency due to the limited time before the
infected cells dies (Nakabayashi and Sasaki 2009). After replication, the HSV virus must
assemble prior to lysing the host cell. Herpesvirus capsids form within the nucleus.
Specialized structures house capsid maturation. The nucleocapsids then migrate and
make contact with the inner nuclear membrane; subsequently budding occurs. Cellular
kinases enable this contact by phosphorylation of the nuclear lamins. The nucleocapsids
obtain proteins and acquire an additional envelope as they lyse the host cell. Further
research on the assembly mechanisms will allow for the development o f drugs/treatments
that can target replication and assembly mechanisms individually or in a number of
combinations (Mettenleiter et al., 2009).

Detection/Treatment. HSV-1 infection rates are significantly higher among
young children, ranging in age from birth up until about three years old in comparison to
adults. However, 70-90% of adults will develop HSV-1 antibodies within their lifetime
(Brooks et ah, 2010). Ohana et al (2000) have developed an extremely sensitive and
specific HSV-1 and HSV-2 antibody screening tool. The test detects total antibodies
present and is a better indicator of actual prevalence rates. The testing is intended to
determine if the infection is caused by HSV-1 or HSV-2 however, is not engineered for
mass screenings. The main goal of the screening is to achieve an accurate account of
HSV prevalence (Ohana et ah, 2000).
HSV may infect the body by a number of routes, including the eye. A feature of
all herpes viruses is the ability to reactivate the infection. Recurring infections in the eye
could lead to permanent damage up to and including blindness. Peptide-conjugated
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phosphorodiamidate morpholino oligomers (PPMO) targeting HSV-1 genes may prevent
viral replication in the eyes of rats. This method o f treatment was found to be more
effective against Acyclovir sensitive and/or resistant HSV-1 strains. Results indicate that
topical treatment utilizing PPMOs are most effective on recurrent HSV-1 as the viral load
is lower in reactivation (Moerdyk-Schauwecker et al., 2009).
Bacteriophages are used as the delivery mechanism for some DNA vaccines.
Mice receiving injections containing recombinant phage are able to induce antibody
production and elicited immune responses that were significantly higher than the control
groups. Bacteriophages are cost-effective and safe method to administer vaccinations
against infections and cancer. However, further research is required to indicate the
potential usage of bacteriophage vaccines for HSV-1 protection and the degree of
immunity provided (Hashemi et al., 2010; Parsania et al., 2010). Some suggested ways to
improve DNA vaccinations were to include a nontoxic adjuvant that would heighten the
immune response, and administer the vaccine with an antigen that would prolong the life
cycle of dendritic cells. Co-injection o f proapoptotic box gene with a HSV-1 plasmid
exhibited increased immune response. A moderate amount of Bax plasmid is necessary
for enhanced immune response. Expression vectors, doses of vaccination, regimens of
vaccine and route of administration require further evaluation (Parsania et al., 2010).
Currently, there are antiviral drugs available as a treatment to reduce the number of
recurrences, shorten healing time, and suppress the infection. However, there are not any
preventative methods to combat HSV-1 infections.
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Tea and Tea Extracts
Background and Uses of Polyphenols. Camellia sinensis is a plant whose leaves
when processed will produce tea in all its available forms. The fermentation level
determines tea categories such as, green (unfermented), black (fermented), and oolong
(partially fermented) (Cheng 2006). Theaflavins are a natural antioxidant, derived from
tea, which have been shown to have a greater antioxidant effect than vitamin E (Shiraki et
al., 1994). The inhibition stems from decreased superoxide production. Experiments have
shown that theaflavins target cell-signaling pathways in tumors and as a result are able to
suppress cancer (Park and Dong, 2003). Theaflavins are also able to inhibit the initiation
of tumor formation thereby preventing carcinogenesis (Mari et al., 1999; Maniti et al.,
2002). Inhibition of inflammation occurs after theaflavin ingestion. Theaflavins can
inhibit viral adsorption into the cell but seem to lack an effect on viral replication in cells
infected with influenza, rotavirus, or enteroviruses (Mikio et al., 1990; Mukoyama et al.,
1991). A number of diseases can benefit from regular theaflavin intake such as:
hyperglycemia, atherosclerosis, heart disease, cancer, and aging. Black tea theaflavins
may be beneficial in future pharmacological developments (Wang and Li 2006). Bonnely
et al. (2003) created a new model set up to effectively oxidize tea leaves while
maintaining high polyphenol levels and reducing or removing the majority o f impurities.
The oxidation of tea leaves over two hours was found to be most effective.
Polyvinylpolypyrolidone (PVPP) removed additional polyphenol substances to increase
accuracy of the activity measurement. The model oxidation system required no buffer,
and indicated that agitation of tea leaves in water does not affect the tea’s enzymatic
activity (Bonnely et al., 2003).
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The antioxidant activity of the Camellia sinensis plant has been suggested to
protect against atherosclerosis. Polyphenols have exhibited positive effects on
hypertension cases. The reduced incidences o f atherosclerosis have the ability to reduce
diabetic mortality. It is unknown if tea drinking should be recommended to diabetics or
those at risk. However, recent studies have indicated green tea may be beneficial in
metabolic syndromes (Campbell 2004). Green tea has a higher antioxidant level than
black tea. Both green and black tea cause a similar degree o f microbial degradation
(Cheng 2006). Regular consumption of green tea has been found to reduce oxidative
damage within the body (Erba et al., 2005). Green tea is often more effective than black
tea as an antioxidant. The effects of the green or black teas’ antioxidant functions are
short lived and best results are experienced with repeated tea intake (approximately 6
cups daily) for several days (Klaunig et al., 1999). Tea consumption has an inverse
relationship with developing gastric cancer as well as some other cancers. Tea
polyphenols have also been used as a topical treatment. Additionally, tea consumption is
beneficial in cardiovascular disease, diabetes and obesity (Khan and Mukhtar 2007).
Animal models were created to mimic diabetes and tea catechins, such as
epigallocatechin gallate (EGCG), that exhibited antidiabetic and antiobesity effects (Kao
et al., 2006). Green tea catechins’ biological activity has been well studied and
documented. However black tea requires further inquiry (Vinson 1998). Investigations
found increased catechin levels in the blood after black tea ingestion (Leenen 2000).
Black tea was determined to not have diminished antioxidation properties; rather,
theaflavins contain more hydroxyl groups than catechins, which are key to scavenging
free radicals (Leung et al., 2001). There are additional antioxidative features, such as
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black tea polyphenols binding to transition metal ions. EGCG affected free radicals via
reduction of reductase activity (Rice-Evans et al., 1997). Previous research has indicated
that epigallocatechin gallate (EGCG) is able to inhibit influenza when there is direct
contact. EGCG and epicatechin gallate (ECG) were determined to inhibit influenza
growth in all strains of influenza. A strong inhibitory effect was evident after analyzing
plaque assays of influenza infected Madin-Darby canine kidney (MDCK) cells, which led
to the belief that the catechins were combating multiple steps o f the viral cycle (Song et
al., 2005). Black tea also protects against oxidation o f phospholipids in the membrane.
Some previous black tea studies have indicated theaflavins may cause some oxidative
damage occasionally resulting in apoptosis (Oikawa et al., 2003). Although further
research is required to understand the conditions to which theaflavins are best used for
health benefits (Luczaj and Skrzydlewska 2005), research indicates that black tea extract
can prolong the average lifespan and increase survival of fruit flies. Black tea extract has
contributed to upregulation of superoxide dismutase (SOD) and catalase (CAT) resulting
in increased fruit fly lifespan. SOD and CAT expression decreases with aging so there
could be a correlation between BTE intake and extended life (Peng et al., 2007).
Scavenging of free radicals and upregulation o f antioxidant enzymes as a result o f black
tea intake may be the mechanisms by which the fruit fly life is extended (Gutteridge and
Halliwell, 2000). Additionally, Kitani et al. (2007) reported that the inclusion of BTE in
water consumed by male mice increased their life span by 6.4%. There is no evidence
that this same result will occur in humans, however the ingestion o f black tea may
prevent premature death (Nakachi et al., 2003).
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Antiviral Studies. Black tea theaflavins were found to have antimutagenic
activities in microbial systems. Tea functions through inhibition o f reductase and
enzymes, induction of detoxification pathways and removal o f free radicals and
electrophiles (Apostolides et ah, 1996). Previously, researchers hypothesized that the
mechanism by which tea exhibited anti-mutagenic properties was through enzyme
inhibition (Bu-Abbas et al., 1994) Black tea blocks the production of free radicals; it also
protects DNA and may reverse many mutagenic changes (Hasaniya et al., 1997).
Khan et al. (2005) reviewed various natural forms o f anti-HSV extracts and
compounds. Researchers described 18 different plants that were tested to determine their
antiviral effects on HSV infected Vero cells. Plantago major L extract exhibited minimal
anti-HSV effects. High concentrations o f Melia dubia, and Cryptostegia grandiflora
displayed partial antiviral activity. Approximately 11 medicinal plant extracts derived
from Thailand exhibited a reduction in HSV plaque formation. Some plants, Hemidesmus
indicus, Paederia foetida, and Shorea robusta were shown to exhibit antiviral resistance
against herpes strains resistant to Acyclovir (Khan et al., 2005). Plant extract, derived
from Rhododendron ferrugineum, was used to prevent viral absorption and penetration.
These results imply the use of polyphenols from other plant types as possible antiviral
substances. Further research is required to determine which surface locations on the
viruses are affected by polyphenols (Khan et al., 2005).
Attachment of virus to host cells was affected by extracts o f Rhododendron
ferrugineum and increased concentrations o f the substance inhibited penetration.
Attacking the viral envelope produced the most anti-adhesive effect on HSV infections
(Gescher et al., 2011). Concentrated tea extract was more effective than diluted or
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mixtures of polyphenols at inhibiting influenza virus replication. Antiviral activity is
observed throughout the infection cycle leading to the conclusion that the primary target
is the membrane. Catechins may also affect conformation and virus-host cell interaction
but more investigation is required (Song et al., 2005).
Black tea, derived from Camellia sinesis, has approximately 1/10 o f the catechins
in green tea. The black tea theaflavins inhibited growth and triggered apoptosis in
cancerous cells. Immortalized cells were more affected by theaflavin cytotoxicity than
normal cells. Theaflavins were found to inhibit growth of abnormal cells and may have a
protective role against human cancers. Toxicity o f theaflavins was dependent on length of
exposure time, and thought to occur as a result of antioxidant action. Cytotoxic effects of
black tea theaflavins are thought to cause cell cycle arrest and induce apoptosis (Babich
et al., 2006).
Black tea theaflavins were found to be more effective against HIV activity than
green tea catechin derivatives. Four theaflavins inhibited HIV-1 replication, while
maintaining minimal cytotoxicity. Approximately seven theaflavins inhibited cell fusion
in HIV cells. Results indicated that tea polyphenols were unable to prevent coreceptor
binding in HIV however, black tea polyphenols inhibited HIV entry by disrupting
formation of the glycoprotein 41 (gp41) six helix bundle, subunit of the envelope. EGCG
combated HIV infection by three mechanisms: inhibition o f HIV-1 reverse transcriptase
activity, binding to cellular glycoprotein CD4 and preventing interaction with
glycoprotein 120 (gpl20), and destroyed viral particles. EGCG blocked viral entry of
influenza and may inhibit entry of HIV-1 (Liu et al., 2005).
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The antiviral effects that black tea extracts (BTE) have exhibited on HIV and
influenza (Song et al., 2005; Liu et al., 2005) coupled with green tea’s catechin
effectiveness has led to the proposed use o f BTE to inhibit Herpes simplex virus 1
replication in cultured cells (Khan et al., 2005). Tea polyphenols have inhibited HIV
entry and replication of influenza when in contact with the respective viruses. It is
reasonable to presume that HSV-1 may demonstrate similar outcomes when exposed to
BTE. Therefore the goal of this project is to determine the lowest inhibitory concentration
of black tea extract that would affect Herpes simplex virus 1 infection o f cultured cells.
Plaque assays will be used to quantify the viral inhibition at various concentrations of
BTE. Subsequently, spectrophotometry, DNA extraction and gel electrophoresis will be
utilized to determine the effect on viral replication.
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Materials and Methods
Cells
Cell line. African green monkey kidney (Vero) cells [American Type Culture
Collection (ATCC), Manassas, VA, USA] were grown in ATTC-formulated Dulbecco’s
Modified Eagle’s Medium (Catalog No. 30-2002), which is composed o f ImM sodium
pyruvate, 4mM L-glutamine, 1500 mg/L sodium bicarbonate and then supplemented to
contain fetal bovine serum (FBS) (Biowest, Miami, FL, USA) to a final concentration of
5%.

Cell cultures. Vero cells were kept in T25 flasks with 5 mL 5% FBS-DMEM in
an incubator at 37°C with an atmosphere o f 5-7.5% CO 2 . To passage the cells, the media
was removed and the cells were washed twice with IX phosphate buffered saline (PBS)
(Fisher Scientific, Fair Lawn, NJ, USA). Cells were trypsinized with 0.5 mL o f IX
trypsin-EDTA (Mediatech Incorporated, Manassas, VA, USA) at 37°C with an
atmosphere of 5-7.5% CO 2 for approximately 5 minutes to detach cells. Cells are
maintained at a 1:3 to 1:6 ratio and subcultured one to two times per week. □

Virus
A recombinant strain of HSV-1, GHSV-UL46, which contains the sequence for
green fluorescent protein (GFP) fused to the tegument protein pUL46, was used for all
experiments (Willard, 2002) (ATCC, Manassas, VA, USA).D

Black Tea Extract (BTE)
Black tea extract: 80% theaflavins (BTE)(10 mg/mL) (Sigma-Aldrich,Saint Louis,
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MO, USA) was dissolved in 1 mL of 10% FBS-DMEM (Mediatech Incorporated,
Manassas, VA, USA) to produce a stock concentration of 10 mg/mL o f BTE solution.
Ten-fold dilutions of stock were stored in Eppendorf tubes at 4°C.

Viral Inhibition
Virus-treated cells. Vero cells were plated in 6-well plates with 2.5 mL o f cell
suspension added to each well and incubated at 37°C with an atmosphere o f 5% CO 2 until
confluent, about 24 - 48 hours. The media was aspirated and cells were treated with 100
pL of each of the four concentrations of BTE solution; as controls, 100 pL of 5% FBSDMEM was added to two separate wells. Plates were rocked to ensure complete coverage
and kept in an incubator at 37°C with an atmosphere of 5% CO 2 for 30 minutes. Any
unabsorbed solution was aspirated and 100 pL of stock virus was added to each well,
with the exception of one of the two wells to which 100 pL of 5% FBS- DMEM was
added, which served as a control (mock-infected). The cells were returned to an incubator
at 37°C with an atmosphere of 5% CO 2 for 1 hour and rocked every 15 minutes to ensure
complete coverage. After 1 hour, any unabsorbed virus was aspirated from each well and
2.5 mL 5% FBS- DMEM was added to each well. The plates were returned to the
incubator and kept at 37°C with an atmosphere o f 5% CO 2 . The media from each well
was harvested after 48 hours and transferred to cryogenic vials, which were stored at 80°C.

Plaque assay. To determine viral titers, ten-fold serial dilutions o f virus-treated
cells were performed by taking 100 pL o f the desired treated media and combining it with
900 pL of 1% FBS-PBS, which was made by mixing 0.5 mL o f FBS with 49.5 mL of
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PBS, to produce the first, 10'1, dilution. Further dilutions proceeded in the same fashion,
in which the starting solution was the previously made diluted solution. To the wells o f a
6-well plate that contained a confluent monolayer of Vero cells, from which media had
been aspirated, 500 pL of 1% FBS-PBS was added as a control to the first well, and 500
pL of the third through seventh (10'3-10'7) dilutions were separately added to each o f five
remaining wells. This process was replicated for each desired concentration of BTE
extract that was studied. The plates were returned to an incubator at 37°C with an
atmosphere of 5% CO 2 for 1 hour and rocked every 15 minutes to ensure thorough
coverage; after 1 hour, any unabsorbed virus was aspirated from each well. Following
this, a nutrient agar was poured over each well. The nutrient agar consisted of a mixture
o f two components, Solutions A and B, that were kept in separate flasks in a 41°C water
bath prior to use. Solution A contained the following in an autoclaved Erlenmeyer flask:
17 mL of 3X Eagle (Gibco Invitrogen Corporation, Grand Island, NY, USA), 1.0 mL o f
5% sodium bicarbonate (Gibco Invitrogen Corporation, Carlsbad, CA, USA), 0.5 mL
FBS, 0.1 mL DEAE-dextran (ICN Biomedicals Incorporated, Aurora, OH, USA), 0.1 mL
penicillin/streptomycin (Cambrex, Walkersville, MD, USA), and 0.05 mL gentamicin.
Solution B consisted of mixing 30 mL MQ water and 0.2 g o f agar bacteriological (Oxoid
Limited, Baskingstoke, Hampshire, England) and autoclaved. After 1 hour incubation,
combine Solutions A and B and overlay cells with 4 mL of plaque media. Once
solidified, store plates in an incubator at 37°C with an atmosphere o f 5% CO 2 for 72
hours. After 72 hours incubation, remove agar and stain cells with crystal violet. The
number of plaques formed in each well was counted to determine the titer in plaque
forming units (PFU) per milliliter.
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DNA extraction. DNA was extracted from infected Vero cells that contained 100
pL HSV-1 virus, 100 pL HSV-l/BTE lysate (0.1 mg/mL), 100 pL HSV-l/BTE lysate
(0.01 mg/mL), 100 pL HSV-l/BTE lysate (1.0 pg/mL), and 100 gL HSV-l/BTE lysate
(0.1 gg/mL), respectively. Cells were incubated for 24 hours at 37°C with an atmosphere
of 5% C 02. The DNA from each of the five groups of cells was extracted with the
Qiagen DNeasy® Blood & Tissue Kit (Qiagen Sciences, Germantown, MD, USA),
following the protocol provided by the manufacturer for cultured cells.

Polymerase chain reaction (PCR). Viral DNA was amplified by PCR. The
primers were for sequences specific for the strain of HSV-1 used in all experiments,
which coded for glycoprotein D (gD) and GFP. The following virus-specific primers
were used: Glycoprotein D:D
gD2F. 5'-TTGTTTGTCGTCATAGTGGGCCTC-3'
gD2R. 5'-TGGATCGACGGTATGTGCCAGTTT-3'
Green Fluorescent Protein (Willard, 2002):
GFP IF. 5'-GTCAAAGCTTAAGATGGTGAGCAAGG-3'
GFP1R. 5'-CTTGAAGCTTCTTGTACAGCTCGTCC-3'

Gel electrophoresis. PCR products were visualized on a 1% agarose gel.
DNA quantification. To quantify the total amount o f DNA in both the extracted
DNA and PCR products, a NanoDrop ND-1000 Spectrophotometer with accompanying
computer software (NanoDrop Technologies Incorporated, Wilmington, DE, USA) was
utilized, following the protocol provided by the manufacturer.

Results
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Viral Inhibition
Virus treated cells. In order to visualize the cytopathic effect (CPE) o f HSV-1
on Vero cells, treated and untreated Vero cells were observed with a light microscope.
Differences could be observed between the cytopathic effects o f cells treated with the
highest concentration BTE (0.1 mg/mL) and the lowest concentration o f BTE (0.1
pg/mL). Cells treated with 0.1 pg/mL BTE exhibited CPE, rounded and detached cells,
close to that o f untreated HSV-1. The cells treated with higher concentrations o f BTE
(0.1 mg/mL, 0.01 mg/mL), exhibited few cells displaying CPE. However, the control
group treated with 5% FBS-DMEM had few dying cells.
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Plaque Assay. In order to investigate the effect of BTE on HSV-1 infection,
plaque assays (Figure 1) were conducted on untreated HSV-1 for use as a comparison to
treated plates. Plaque assays were also conducted by infecting the monolayers o f Vero
cells with viral media harvested from infected cells previously treated: 0.1 mg/mL, 0.01
mg/mL, 1.0 pg/mL, or 0.1 pg/mL (Figure 2).

Figure 1. Schematic diagram of the set-up for plaque assays. Each o f the six wells,
confluent with Vero cells, were treated with a different dilution o f either untreated HSV-1
or HSV-1 treated with BTE. The 1st well contained no virus and served as a control.
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Neg. Control
Mock infected
1% FBS-PBS

10-5

10-4

10-6

10-7

Figure 2. Plaque assay for HSV-1 lysate harvested from O.ljig/mL concentration o f BTE
in cultured Vero cells. At the 1O'4 viral dilution, the viral titer is calculated to be 3.4 x 105
PFU/mL.
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The viral titer produced by HSV-1 alone and when treated with various
concentrations of BTE was determined by plaque assays (Figure 1). The viral titer for
HSV-1, 1.0 pg/mL and 0.1 pg/mL were determined (Table 1). The untreated HSV-1 viral
titer is 8.0 x 106 PFU/mL (plaque forming units per milliliter). The viral media harvested
from infected cells treated with 1.0 pg/mL BTE produced 15 plaques for 0.5mL/well of
viral solution at the 10'4 dilution resulting in a viral titer o f 3.0 x 105 PFU/mL. However,
the infected cells treated with 0.1 pg/mL BTE produced similar results as infected cells
treated with 1.0 pg/mL BTE, 17 plaques for 0.5 mL/well of viral solution at the 10'4
dilution, thus calculating a viral titer o f 3.4 x 105 PFU/mL.

Table 1
Plaque assay results
Vero Sample
Untreated HSV-1
BTE Treated HSV-1 (1.0 pg/mL)
BTE Treated HSV-1 (0.1 pg/mL)

Viral titer (PFU/mL)
8.0 x 106
3.0 x 105
3.4 x 105
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DNA extraction and Spectrophotometric Analysis. To compare the amount of
DNA present in Vero infected cells exposed to either untreated or BTE treated HSV-1,
Vero cells were either exposed to 5% FBS-DMEM (mock-infected), untreated HSV-1
(HSV-1 suspended in 5% FBS-DMEM) or HSV-1 treated with four serial dilutions of
lysate 4 (0.1 pg/mL BTE treated HSV-1). The DNA from these cell samples was
extracted and compared using a spectrophotometer (Table 2). The cells infected with
untreated HSV-1 were shown to have relatively the same amount o f DNA present (50.6
ng/pL) as compared to infected cells exposed to BTE treated HSV-1 (53ng/pL [O.Olpg/mL BTE treated HSV-1], 45.2 ng/pL - [1.0 ng/mL BTE treated HSV-1],
66.1ng/pL - [0.01 ng/mL BTE treated HSV-1]). However, 0.1 ng/mL o f BTE treated
HSV-1 resulted in a lower concentration DNA (38.5 ng/pL), which may indicate a
reduction in the replication of viral DNA and thus, viral inhibition.
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Table 2
Comparison o f DNA from infected Vero Cells
Vero Sample
Untreated HSV-1
BTE Treated HSV-1 (.1 mg/mL)
BTE Treated HSV-1 (0.01 mg/mL)
BTE Treated HSV-1 (1.0 |tg/mL)
BTE Treated HSV-1 (0.1 pg/mL)

Total DNA Present (ng/pL)
50.6
53
45.2
38.5
66.1

Note. For each sample, the total DNA present denotes a combination of cellular and any
viral DNA. Vero cells were infected with HSV-1 that was either untreated or treated with
four serial dilutions of the 0.1 pg/mL sample (0.01 pg/mL - 0.01 ng/mL BTE treated
HSV-1). The spectrophotometer determined the amount o f DNA present by analyzing 2
pL of each sample. As a blank, 2 pL o f the elution buffer was utilized and registered as
0.0 ng/pL (data not shown).
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PCR and gel electrophoresis. To determine if replication of HSV-1 DNA was
affected by the treatment with BTE, two sets of viral primers were used in PCR to
amplify any viral DNA extracted from infected cells. Sequence-specific primers were
used to amplify the DNA encoding gD and GFP. Gel electrophoresis o f the PCR products
resulted in no visible bands on the gel corresponding to gD, however bands on the gel
corresponding to GFP were apparent for all untreated and treated HSV-1 (0.01 pg/mL,
1.0 ng/mL, 0.1 ng/mL, 0.01 ng/mL). These results indicate a direct correlation between
the decrease o f BTE concentration and the intensity of samples containing GFP. The
intensity o f samples 0.01 pg/mL (column 2) and 1.0 ng/mL (column 4) indicate that
larger quantities of DNA fragments are present as opposed to the lower intensity
observed in samples 0.1 ng/mL (column 6) and 0.01 ng/mL (column 10).
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Figure 3. Gel electrophoresis of PCR products extracted from HSV-1 infected Vero cells
either treated with BTE (columns 4 - 10) or untreated (columns 2 - 3). Column 1 contains
the DNA ladder, with visible bands identified to the left in base pairs (bp). Columns 2, 4,
6, 8, and 10, and 3, 5, 7, and 9 contain DNA amplified with primers for the HSV-1 GFP
and gD genes, respectively.
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Column

Figure 4. Gel electrophoresis of PCR products extracted from HSV-1 infected Vero cells
treated with BTE (Column 2). Column 1 contains the same DNA ladder seen in the
previous gel (Figure 3). Column 2 contains DNA amplified with primers for the HSV-1
gD gene.
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Discussion
The leading consumed beverage worldwide, after water, is tea. For over 50
centuries, tea has been recognized for its medicinal uses as an herbal treatment of
multiple ailments from simple indigestion to atherosclerosis (Cheng, 2006; Khan and
Mukhtar, 2007). Tea is available in multiple forms including, green, black and oolong, of
which all contain polyphenols. Theaflavins, black tea polyphenols, are a natural
antioxidant and inhibits viral adsorption into cells. As such, theaflavins may be useful in
future pharmaceutical developments (Wang and Li 2006).
Herpes simplex virus is found all over the world and 70 - 90% o f adults have
HSV-1 antibodies. Once contracted, the primary infection lasts approximately 10 days
with an average of 2-6 recurrences per year. There are about 300,000 HSV eye infections,
as well as cases of HSV encephalitis which if left on treated results in death for 7 out of
every 10 incidences. HSV-1 infection is not restricted to adults, as neonatal herpes occurs
approximately 1 in 5000 deliveries each year (Whitley and Roizman, 2001; Brooks et al.,
2010). Maternal infections are transferred to 30-50% o f vaginally delivered neonates. To
combat HSV-1 infection, Acyclovir is the drug o f choice as it inhibits viral DNA
synthesis, shortens healing time and can reduce the number of HSV recurrences.
Nevertheless, HSV maintains the ability to establish latent infections within the neurons
and also develop a resistance to Acyclovir and other related drugs (Brooks et al., 2010).
The purpose of this study was to assess the antiviral qualities of black tea extracts
and determine the lowest inhibitory concentration against HSV-1. Black tea extract has
previously been found to block the production of free radicals, inhibited growth of
cancerous cells, as well as exhibited cytotoxic effects against immortalized cells (Babich
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et al., 2006). BTE also inhibited viral activity o f both HIV and influenza. If the lowest
inhibitory concentration could be determined, future research could then be done to
determine its effectiveness in conjunction with Acyclovir or as an alternative for
Acyclovir resistant strains of HSV-1.
Previous research conducted in this lab determined the cytotoxicity o f BTE as
well as the highest concentration of BTE that can be used without causing toxic effects.
Vero cells were treated with concentrations o f BTE (0.1 mg/mL, 0.01 mg/mL, 1.0 pg/mL,
0.01 pg/mL, respectively), infected with HSV-1, and then the lysate was harvested.
Inhibition o f viral activity can be due to various mechanisms such as inhibition o f viral
entry, DNA replication, or any other step in the process o f creating viral progeny. HSV-1
inhibition was observed through conducting plaque assays utilizing the previously
obtained lysates. Data from each plaque assay indicated that inhibition occurred when
compared to the HSV-1 assay.
DNA extracted from cells infected with each dilution o f the lysate resulting from
treatment of Vero cells with 0.01 pg/mL of BTE were analyzed by spectrophotometer.
All the extracts had relatively similar concentrations of DNA; meanwhile, the DNA
extracted from Vero cells treated with 0.1 ng/mL o f BTE resulted in a lower DNA
concentration than was present in any of the other samples including untreated HSV-1
(Table 2). This result indicates that there may be some viral inhibition taking place since
there is less DNA found in the sample. To determine if replication of HSV-1 DNA was
affected by treatment with BTE, PCR was used to amplify the DNA extracted from
infected Vero cells and PCR products were visualized using agarose gel electrophoresis.
Genome specific primers for GFP amplified the DNA extracted from each infection. The
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gel electrophoresis also confirmed the spectrophotometer results as all PCR samples had
a band at 750 bp, the approximate size o f the GFP (727bp). If there is inhibition, the
mechanism is not known. Oikawa et al. (2003) state that theaflavins may cause some
oxidative damage. However, prior research in this lab found that various concentrations
of BTE (10 —10"8 mg/mL) exhibited no cytotoxic effects. The concentration o f BTE in
the 0.1 ng/mL sample may be low enough to perform viral inhibition without inflicting
additional cytopathic affects against the Vero cells. Furthermore, the concentration o f
BTE in the 0.01 ng/mL sample may be below the required threshold to exhibit inhibition
and thus the viral DNA levels increase back to the concentrations found within untreated
HSV-1 and the other dilutions of lysate 0.1 pg/mL.
It appears that 0.1 ng/mL is the lowest concentration that exhibits inhibitory
effects on HSV-1. It remains to be determined the mechanism by which inhibition is
occurring. Current antiviral drugs, such as Acyclovir, inhibit viral DNA synthesis
(Brooks et al., 2010). There are also other means of inhibition that BTE could be acting
upon such as attachment, penetration, or BTE could be slowing the replication cycle.
In conclusion, the 0.1 ng/mL sample was found to contain the lowest
concentration of BTE that exhibits inhibitory effects on HSV-1. Previous research in this
lab showed reduction due to binding to human epithelial A549 cells. This is also a
possible mechanism for inhibition in Vero cells. The determination o f which mechanism
BTE is exploiting to reduce viral activity remains to be found. Further studies will be
beneficial as BTE is a readily available substance and has a history o f improving health
with regular usage.
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